In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients | Zendy

Donald R. VanDevanter | Zendy; Jill M. Van Dalfsen | Zendy; Jane L. Burns | Zendy; N. Mayer-Hamblett | Zendy

Open Access

In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

Author(s) -

Donald R. VanDevanter,

Jill M. Van Dalfsen,

Jane L. Burns,

N. Mayer-Hamblett

Publication year - 2013

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pit052

Subject(s) - pseudomonas aeruginosa , cystic fibrosis , antibiotics , medicine , microbiology and biotechnology , isolation (microbiology) , bacteria , biology , genetics

Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research